Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Treatment of chronic bacterial infections, such as tuberculosis (TB), requires a remarkably long course of therapy, despite the availability of drugs that are rapidly bacteriocidal in vitro. This observation has long been attributed to the presence of bacterial populations in the host that are "drug-tolerant" because of their slow replication and low rate of metabolism. However, both the physiologic state of these hypothetical drug-tolerant populations and the bacterial pathways that regulate growth and metabolism in vivo remain obscure. Here we demonstrate that diverse growth-limiting stresses trigger a common signal transduction pathway in Mycobacterium tuberculosis that leads to the induction of triglyceride synthesis. This pathway plays a causal role in reducing growth and antibiotic efficacy by redirecting cellular carbon fluxes away from the tricarboxylic acid cycle. Mutants in which this metabolic switch is disrupted are unable to arrest their growth in response to stress and remain sensitive to antibiotics during infection. Thus, this regulatory pathway contributes to antibiotic tolerance in vivo, and its modulation may represent a novel strategy for accelerating TB treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the contrary, in a TraSH screen selecting for mutants that continue to replicate under hypoxic conditions Baek and coworkers (40) found SDH2 mutants overrepresented.”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
Self-citationEvans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Mycobacterial persistence requires the utilization of host cholesterol
Pandey, A. K., & Sassetti, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711159105 · Cited by 1,064 · cited 1×
“availability [4–7].”
Self-citationPark, H., Guinn, K. M., Harrell, M. I., Liao, R., Voskuil, M. I., Tompa, M., Schoolnik, G. K., & Sherman, D. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03474.x · Cited by 712
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Comprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616
Self-citationM. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Cited by
Items 201–300 of 334
Antibiotic Lethality and Membrane Bioenergetics
Voskuil, M. I., Covey, C. R., & Walter, N. D. (2018) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2018.06.002 · Cited by 12
Over-expression of Tgs1 in Mycobacterium marinum enhances virulence in adult zebrafish
Liu, D., Zhang, J., Pan, Z.-F., Mai, J., Mei, H., Dai, Y., Zhang, L., & Wang, Q. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.151378 · Cited by 12
Xu, Y., Zhang, Z., & Sun, Z. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.860948 · Cited by 15
Wu, Z., Wei, W., Zhou, Y., Guo, H., Zhao, J., Liao, Q., Chen, L., Zhang, X., & Zhou, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01572 · Cited by 12
Zhou, Z., Bai, S., He, J., Xiong, Q.-X., Zhong, Z. A., Lu, C., Kuang, L.-F., Jian, Z., Gu, J., Liu, M., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107715 · Cited by 11
González-Escalante, L. A., Peñuelas-Urquides, K., Said‐Fernández, S., Silva-Ramírez, B., & de León, M. B. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv194 · Cited by 14
Lanni, F., Wijnant, G.-J., Xie, M., Osiecki, P., Dartois, V. A., & Sarathy, J. P. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102318 · Cited by 12
Molecular analysis of the Mycobacterium tuberculosis lux-like mel2 operon
Janagama, H. K., Sambou, T., Cirillo, S. L. G., Zinniel, D. K., Barletta, R. G., & Cirillo, J. D. (2013) · Tuberculosis · doi:10.1016/s1472-9792(13)70016-7 · Cited by 11
Molecular Mechanisms of Drug Tolerance in Mycobacterium tuberculosis
Антонова, А. В., Gryadunov, D. A., & Zimenkov, D. V. (2018) · Molecular Biology · doi:10.1134/s0026893318030020 · Cited by 12
Zhou, W., Huang, S., Cumming, B. M., Zhang, Y., Tang, W., Steyn, A. J. C., Chen, S., & Hu, Y. (2022) · mBio · doi:10.1128/mbio.03343-21 · Cited by 11
Hoyle, R. B., Avitabile, D., & Kierzek, A. M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002396 · Cited by 10
Oh, Y., Lee, H.-I., Jeong, J.-A., Kim, S., & Oh, J. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2202-0 · Cited by 10
Proteomic analysis of Streptomyces coelicolor in response to Ciprofloxacin challenge
Rao, A. A., Patkari, M., Reddy, P. J., Srivastava, R., Pendharkar, N., Rapole, S., Mehra, S., & Srivastava, S. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.08.013 · Cited by 10
Baron, V. O., Chen, M., Clark, S. O., Williams, A., Dholakia, K., & Gillespie, S. H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7638-6_4 · Cited by 10
Amanzougaghene, N., Tajeri, S., Franetich, J., Ashraf, K., Soulard, V., Bigeard, P., Guindo, C. O., Bouillier, C., Lemaître, J., Relouzat, F., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107112 · Cited by 9
Vergoz, D., Dé, E., Loutelier‐Bourhis, C., & Alexandre, S. (2025) · Environmental Microbiology · doi:10.1111/1462-2920.70207 · Cited by 10
Adolph, C., Hards, K., Williams, Z. C., Cheung, C., Keighley, L. M., Jowsey, W. J., Kyte, M., Inaoka, D. K., Kita, K., Mackenzie, J. S., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00655 · Cited by 10
Stevens, M. T., Hawkins, P. M. E., Wang, T., Payne, R. J., & Britton, W. J. (2024) · Tuberculosis · doi:10.1016/j.tube.2024.102594 · Cited by 9
Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli
Sau, S., Roy, A., Agnivesh, P. K., Kumar, S., Guru, S. K., Sharma, S., & Kalia, N. P. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001695 · Cited by 9
Upregulated Palmitoleate and Oleate Production in Escherichia coli Promotes Gentamicin Resistance
Ye, G., Fan, L., Zheng, Y., Liao, X., Huang, Q., & Su, Y. (2024) · Molecules · doi:10.3390/molecules29112504 · Cited by 8
Oluoch, P. O., Koh, E., Proulx, M. K., Reames, C. J., Papavinasasundaram, K. G., Murphy, K. C., Zimmerman, M., Dartois, V. A., & Sassetti, C. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417525122 · Cited by 8
Self-citationDiversity of glpK Gene and Its Effect on Drug Sensitivity in Mycobacterium bovis
Dong, Y., Ou, X., Liu, C., Fan, W., Zhao, Y., & Zhou, X. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s346724 · Cited by 8
Chao, W.-C., Huang, Y., Yu, M.-C., Yang, W.-T., Lin, C.-J., Lee, J., Huang, R., Shieh, C.-C. K., Chien, S.-T., & Chien, J. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0795-1 · Cited by 8
A temperature-induced metabolic shift in the emerging human pathogen Photorhabdus asymbiotica
Carter, E. L., Waterfield, N. R., Constantinidou, C., & Alam, M. T. (2024) · mSystems · doi:10.1128/msystems.00970-23 · Cited by 8
Guo, J., Jia, Z., Yang, Y., Wang, N., Xue, Y., Li, X. F., Wang, F., Wang, L., Wang, X., Liu, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114415 · Cited by 8
Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters
Eldesouky, H. E., Jones, R. M., Gleason, N., Mohammed, S., 邢恩明, Li, P.-K., & Sherman, D. R. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00298 · Cited by 7
Aerobic soil bacteria adapt to hypoxia by hybridizing fermentation with carbon storage
Gillett, D. L., Koralegedara, T., Hutchinson, T. F., Nguyen-Dinh, T., Watts, T. D., Solari, J., Mudaliyar, M., Jowsey, W. J., Athukorala, N., Wong, W. W., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2606389123 · Cited by 8
Park, H.-E., Kim, K.-M., Trinh, M. P., Yoo, J., Shin, S. J., & Shin, M. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00683-6 · Cited by 7
Genetic Strategies for Identifying New Drug Targets
Trauner, A., Sassetti, C. M., & Rubin, E. J. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0030-2013 · Cited by 8
Self-citationMycobacterial Lipid Bodies and the Chemosensitivity and Transmission of Tuberculosis
Garton, N. J., & Barer, M. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-72473-7_6-1 · Cited by 7
Fines, D., Schichnes, D., Knight, M., Anaya-Sanchez, A., Thuong, N., Cox, J. S., & Stanley, S. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552809 · Cited by 7
Kim, H. W., Lee, J., Yoon, H. S., Park, H., Lee, Y. I., Lee, S. K., Whang, J., & Kim, J.-S. (2025) · Virulence · doi:10.1080/21505594.2025.2454323 · Cited by 6
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
Rodriguez‐Rivera, F. P., Zhou, X., Theriot, J. A., & Bertozzi, C. R. (2018) · Angewandte Chemie · doi:10.1002/ange.201712020 · Cited by 6
The DosR regulon of Mycobacterium avium and adaptation to hypoxia
Belardinelli, J. M., Avanzi, C., Martin, K. E., Lam, H., Dragset, M. S., Wheat, W. H., Podell, B. K., Juarrero, M. G., & Jackson, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1545856 · Cited by 6
Yimcharoen, M., Saikaew, S., Wattananandkul, U., Phunpae, P., Intorasoot, S., Tayapiwatana, C., & Butr-Indr, B. (2023) · Antibiotics · doi:10.3390/antibiotics12050852 · Cited by 6
Short-Term Dietary Intervention with Whole Oats Protects from Antibiotic-Induced Dysbiosis
Costa, S. K., Antosca, K. M., Beekman, C. N., Peterson, R. L., Penumutchu, S., & Belenky, P. A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02376-23 · Cited by 6
Interactions of Mycobacterium tuberculosis with Human Mesenchymal Stem Cells
Khan, A., & Jagannath, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_5 · Cited by 6
Sharma, S., Kumar, R. K., Jain, A., Kumar, M., Gauttam, R., Banerjee, R., Mukhopadhyay, J., & Tyagi, J. S. (2021) · Biochemical Journal · doi:10.1042/bcj20210268 · Cited by 6
Shim, D., Kim, H., & Shin, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01601 · Cited by 6
Murdoch, H. M., Dechow, S. J., Abdalla, B. J., & Abramovitch, R. B. (2025) · mBio · doi:10.1128/mbio.02955-25 · Cited by 6
Gallein potentiates isoniazid's ability to suppress Mycobacterium tuberculosis growth
Rijal, R., & Gomer, R. H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1369763 · Cited by 6
Metabolic Perspectives on Persistence
Hartman, T. E., Wang, Z., Jansen, R. S., Gardete, S., & Rhee, K. Y. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch31 · Cited by 5
Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies
Mishra, A. K., Thakare, R., Santani, B. G., Yabaji, S. M., Dixit, S. K., & Srivastava, K. K. (2023) · Biochimie · doi:10.1016/j.biochi.2023.12.009 · Cited by 5
Enhanced Methodologies for Detecting Phenotypic Resistance in Mycobacteria
Hammond, R., Baron, V. O., Lipworth, S., & Gillespie, S. H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7638-6_8 · Cited by 5
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Gold, B. S., & Nathan, C. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch15 · Cited by 8
Gough, A. M., Parker, A. C., O'Bryan, P. J., Whitehead, T. R., Roy, S., Garcia, B. L., Hoffman, P. S., Jeffrey Smith, C., & Rocha, E. R. (2024) · MicrobiologyOpen · doi:10.1002/mbo3.1429 · Cited by 4
Heterogeneity in microbial antibiotic responses: genetic basis and within-host evolution
Liu, Q., & Lyu, L.-D. (2026) · Trends in Genetics · doi:10.1016/j.tig.2026.03.008 · Cited by 4
Zhan, L., Hou, Z., Wang, Y., Liu, H., Liu, Y., & Huang, G. (2022) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00199 · Cited by 4
Santoshi, M., Bansia, H., Hussain, M., Jha, A. K., & Nagaraja, V. (2024) · Molecular Microbiology · doi:10.1111/mmi.15265 · Cited by 4
Pradhan, A., Mukkayyan, N., Jakkala, K., & Ajitkumar, P. (2021) · Cells · doi:10.3390/cells10051160 · Cited by 4
Mycobacterial Lipid Bodies and the Chemosensitivity and Transmission of Tuberculosis
Garton, N. J., & Barer, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-15147-8_6 · Cited by 4
Membrane Proteins as a Regulator for Antibiotic Persistence in Gram-Negative Bacteria
Yee, J. X., Kim, J., & Yeom, J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00024-w · Cited by 4
Transcriptomics Analysis Uncovers Transient Ceftazidime Tolerance in Burkholderia Biofilms
Chattagul, S., Khan, M. M., Scott, A. J., Nita‐Lazar, A., Ernst, R. K., Goodlett, D. R., & Sermswan, R. W. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00003 · Cited by 4
Shi, X., Shi, K.-X., Han, F., Wang, L., Cai, X., Zhao, G., Sha, W., & Lyu, L.-D. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01096-25 · Cited by 3
Alterations in molecular response of Mycobacterium tuberculosis against anti-tuberculosis drugs
Bhattacharjee, A., Sarma, S., Sen, T., & Singh, A. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07095-1 · Cited by 3
Nambiar, R. B., & Yue, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90578-1_15 · Cited by 3
Smith, H., Grant, S. C., Meleady, P., Henry, M. A., O’Gorman, D. J., CLYNES, M. M., & Murphy, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010218 · Cited by 3
Mycobacterium tuberculosis CitA activity is modulated by cysteine oxidation and pyruvate binding
Pathirage, R., Favrot, L., Petit, C., Yamsek, M., Singh, S., Mallareddy, J. R., Rana, S., Natarajan, A., & Ronning, D. R. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00058c · Cited by 3
Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future
Jain, A., Kumar, R., Mothsra, P., Sharma, A., Singh, A. K., & Kumar, Y. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266286294240610102911 · Cited by 4
Wu, Z., Liu, W., Tan, Q., Chen, Y., Lai, X., Hong, J., Liang, H., Wu, H., Liang, J., & Chen, X. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03826-7 · Cited by 3
Mishra, S., Shukla, P., Bhaskar, A., Anand, K., Baloni, P., Jha, R. K., Mohan, A., Rajmani, R. S., Nagaraja, V., Chandra, N. R., et al. (2017) · eLife · doi:10.7554/elife.25624.037 · Cited by 3
Luo, D., Xie, W., Ma, S., Wang, L., Zhu, J., & Wang, Z. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107470 · Cited by 2
Mathur, P., Choudhary, P., Chandrasekaran, R., Singh, R., & Daima, H. K. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.11.001 · Cited by 2
Sebastian, J., Ma, S., Rustad, T. R., Bustad, E., Thomas, A., Singh, S., Kumar, P., Sherman, D. R., & Alland, D. (2025) · Nature Communications · doi:10.1038/s41467-025-67152-2 · Cited by 2
Lawrence, A.-L. E., & Tan, S. (2026) · Science Advances · doi:10.1126/sciadv.aeb8377 · Cited by 2
Black, S., Bowyer, D., Graham, P., Fitzpatrick, L. I., Pate, K., Woodrow, A., & Schwannauer, M. (2021) · Criminal Behaviour and Mental Health · doi:10.1002/cbm.2199 · Cited by 2
The Mycobacterium bovis BCG GroEL1 Contributes to Isoniazid Tolerance in a Dormant-Like State Model
Zeng, S., Yang, D. M., Rens, C., & Fontaine, V. (2023) · Microorganisms · doi:10.3390/microorganisms11020286 · Cited by 2
Antibiotic Resistance in Mycobacteria
Zeng, J., Tan, X., & Gao, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007462 · Cited by 2
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosis
Roszkowski, E. K., Charap, S., Montague, C. R., Sukheja, P., McNamara, C. W., Soma, P. S., Islam, M. N., Graham, B., Grzegorzewicz, A. E., Jackson, M., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111022 · Cited by 3
Antimicrobial-Mediated Bacterial Suicide
Hong, Y., Drlica, K., & Zhao, X. (2018) · Springer eBooks · doi:10.1007/978-3-319-78538-7_20 · Cited by 2
Mycobacteria Infection and Lipid Droplets: Host and Pathogen Stealing, Sharing and Storing Fat
Armstrong, R. M., & Zahrt, T. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_9 · Cited by 2
Host–Pathogen Interactions Influencing Mycobacterium tuberculosis Persistence and Drug Tolerance
Zheng, H., & Abramovitch, R. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-25241-0_10 · Cited by 2
Phenotypic Heterogeneity in Mycobacterium tuberculosis
Dhar, N., McKinney, J. D., & Manina, G. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch32 · Cited by 2
Challenges in Drug Discovery against Tuberculosis
Dwivedi, M., & Giri, P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97857 · Cited by 4
The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage
VanderVen, B. C., Huang, L., Rohde, K. H., & Russell, D. G. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch30 · Cited by 4
Study of Structurally Diverse Currently Used and Recently Developed Antimycobacterial Drugs
Almehmadi, M. M., Abdulaziz, O., Halawi, M., & Asif, M. (2023) · Medicinal Chemistry · doi:10.2174/1573406419666230111111153 · Cited by 4
Hillman, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/747980 · Cited by 2
BacPROTACs outperform inhibitors in Mycobacterium tuberculosisPreprint
Brown, D. A., Davies, J. J., Fecht, S., Zhang, Y., Kunzelmann, S., Kent, L., Skehel, M. J., & Morreale, F. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731830 · Cited by 2
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial Agents
Liu, Q., Engelhart, C. A., Wallach, J. B., Tiwari, D., Ge, P., Manna, A. C., Panda, S., McCue, W. M., Wong, T.-Y., Sharma, S., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02299 · Cited by 1
Maurya, R. K., Fatima, S., Anand, S., Rajmani, R., Bharti, S., Rastogi, S., Venugopal, U., Sinha, A., Singh, A. K., & Krishnan, M. Y. (2025) · Tuberculosis · doi:10.1016/j.tube.2025.102617 · Cited by 1
Chen, S., Zheng, J., Liu, Q., Teng, T., Yang, Z., Huo, F., Xue, Y., Li, L., & Huang, H. (2026) · mSystems · doi:10.1128/msystems.01732-25 · Cited by 1
Tuberculosis: una dinámica continua entre el pasado y el presente, para imaginar el futuro
Cabello, F. C. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000700001 · Cited by 1
[Para-aminobenzoic acid intensification of DNA repair processes in Escherichia coli K-12].
Васильева, С. В., Ls, D., & Rapoport, I. A. (1982) · PubMed · Cited by 5
Mycobacterium tuberculosis Metabolism
Mashabela, G. T., de Wet, T. J., & Warner, D. F. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch67 · Cited by 3
Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex
Shah, Y. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92916 · Cited by 2
Memon, A. A., Fu, X., Fan, X., Xu, L., Xiao, J., Rahman, M. U., Yang, X., Yao, Y., Deng, Z., & Ma, W. (2023) · Microorganisms · doi:10.3390/microorganisms11102505 · Cited by 1
Multiomics technologies applied to tuberculosis drug discovery
Ayaz, O., Ali, A., Ayaz, A., Nazir, A., Ahmad, S. B., Alauddin, Singh, N., Wani, A. B., & Bhat, K. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23971-7.00011-0 · Cited by 2
Mcdowell, J. R. (2021) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/11hv-av1r · Cited by 1
Mouritsen, J. (2014) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010399701
Investigation of mycobacterial survival in non-permissive growth conditions
Sarybaeva, A. A. (2015) · Figshare
Modeling of metabolism and gene expression under hypoxia in Mycobacterium tuberculosis
Elghraoui, A. (2015) · California State University ScholarWorks (system-wide DSpace)
Sanyi, R. H. H. (2016) · Figshare
Antibiotic Efficacy and Interaction in Escherichia coli during Varying Nutrient Conditions
Millar, K. K. (2016) · Scholarship @ Claremont (The Claremont Colleges)
Treatments for Mycobacterial Persistence and Biofilm Growth
Hava, D. L., & Sung, J. C. (2016) · Wiley eBooks · doi:10.1002/9781118943182.ch17
Okay, S. (2016) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2016-0019 · Cited by 1
Fitch, L. E. (2015) · Digital Repository Service (Northeastern University) · doi:10.17760/d20197922
Rittershaus, E. S. C. (2016) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2nk5s · Cited by 1
Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrestPreprint
Baker, J. J., & Abramovitch, R. B. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/186551
Characterising mycobacterial persisters.
Hernández, J. (2020) · University of Surrey Open Research repository · doi:10.15126/thesis.00850531
Tuberculosis Drug Discovery: Target Identification and Validation
Warner, D. F., & Mizrahi, V. (2012) · Springer eBooks · doi:10.1007/978-3-642-28175-4_3 · Cited by 1
Metadata
- Authors
- Baek, S.-H., Li, A. H., & Sassetti, C. M.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Sassetti, Christopher M.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-05-24
- Volume
- 9
- Issue
- 5
- Pages
- e1001065
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC3101192
- OpenAlex
- W2082507312
- Cited by
- 324
- References
- 35
- Citations by year
- 2026: 10 · 2025: 28 · 2024: 24 · 2023: 21 · 2022: 31 · 2021: 23 · 2020: 16 · 2019: 26 · 2018: 25 · 2017: 22 · 2016: 24 · 2015: 26 · 2014: 18 · 2013: 12 · 2012: 12
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI064282, AI073509, R21AI073509, R01AI064282)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Mycobacterium tuberculosis, tuberculosis, antibiotic tolerance, drug-tolerant persisters, triglyceride synthesis, bacterial metabolism, carbon flux, TCA cycle, stress response, signal transduction, bacterial growth regulation, chronic bacterial infection
- MeSH terms
- Acetyl Coenzyme A, Anaerobiosis, Animals, Antitubercular Agents, Bacterial Proteins, Citric Acid Cycle, Ethambutol, Isoniazid, Lung, Mice, Inbred C57BL, Mutation, Mycobacterium tuberculosis, Pyrazinamide, Spleen, Stress, Physiological, Triglycerides, Tuberculosis, Pulmonary, Drug Resistance, Bacterial, Mice, Biosynthetic Pathways, Bacterial Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.